Simon Sturge is Director of MoonLake Immunotherapeutics. Currently has a direct ownership of 171,980 shares of MLTX, which is worth approximately $8.95 Million. The most recent transaction as insider was on Oct 04, 2024, when has been sold 171,000 shares (Class A ordinary shares, par value $0.0001 per share) at a price of $53.72 per share, resulting in proceeds of $9,186,120. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 172K
Infinity% 3M change
Infinity% 12M change
Total Value Held $8.95 Million

Simon Sturge Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 04 2024
SELL
Open market or private sale
$9,186,120 $53.72 p/Share
171,000 Reduced 49.86%
171,980 Class A ordinary share...
Oct 01 2023
SELL
Sale (or disposition) back to the issuer
-
342,980 Reduced 100.0%
0 Class C ordinary share...
Oct 01 2023
BUY
Conversion of derivative security
-
342,980 Added 50.0%
342,980 Class A ordinary share...
SS

Simon Sturge

Director
Zug, V8

Track Institutional and Insider Activities on MLTX

Follow MoonLake Immunotherapeutics and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MLTX shares.

Notify only if

Insider Trading

Get notified when an Moon Lake Immunotherapeutics insider buys or sells MLTX shares.

Notify only if

News

Receive news related to MoonLake Immunotherapeutics

Track Activities on MLTX